Monoclonal antibody production by EBV transformation of B cells

Details for Australian Patent Application No. 2011201553 (hide)

Owner Institute for Research in Biomedicine

Inventors Lanzacecchia, Antonio

Agent FB Rice

Pub. Number AU-B-2011201553

Parent 2004215125

Filing date 6 April 2011

Wipo publication date 28 April 2011

Acceptance publication date 2 June 2011

International Classifications

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C07K 16/20 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/49 (2006.01) Investigating or analysing materials by specific methods not covered by groups - blood

Event Publications

21 April 2011 Complete Application Filed

28 April 2011 Application Open to Public Inspection

  Published as AU-B-2011201553

2 June 2011 Application Accepted

  Published as AU-B-2011201553

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201554-Improved quenching methods for red blood cell inactivation process

2011201552-Definitive endoderm